Luiz Noronha
Partner @ DNA Capital
São Paulo, Brazil
Luiz Noronha is a Series A investor at DNA Capital in São Paulo focused on Health Care and Medical. Luiz Henrique Noronha is a partner at DNA Capital, running its VC practice. He is also an active angel investor.
- Total investments:
- 11
- Last investment:
- Lead investor:
- 55%
Last updated:
For AI agents: llms.txt
Industries Luiz Noronha invests in
Stages Luiz Noronha invests in
Countries Luiz Noronha invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 5 (45%)
- Medical 3 (27%)
- Software 2 (18%)
- InsurTech 2 (18%)
- Health Insurance 2 (18%)
Stage
- Series A 3 (27%)
- Series B 2 (18%)
- Seed 1 (9%)
- Series C 1 (9%)
- Funding Round 1 (9%)
Country
- Brazil 5 (45%)
- China 1 (9%)
- Hong Kong 1 (9%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| The safest and friendliest e-prescribing tool, for doctors. The most convenient and affordable way for treatment adherence, for patients. | $15.9M / May 21, 2026 | ||
| Sanar seeks to reshape future doctors and healthcare professionals to be much more efficient and assertive. We started the company as a knowledge platform; from the first moment they step into college, we follow the evolution of the professional throughout their career. Today, Sanar has become a platform for doctors entire lives, offering solutionsfor different stages of their journey: 1 - For students we offer SanarFlix; the platform has a multitude of content from the best teachers in the country and is helping the students to overcome the challenges they face in college. 2 - For the period of admission to medical residency, Sanar offers Sanar Medical Residency, a platform for test preparation to help doctors to enter the best programs in Brazil. 3 - For the general physician, we offer SanarYellow, a clinical decision-making tool with the most up-to-date guidelines, protocols, and drug interactions for point-of-care. 4 - Sanar is also helping to unlock the doctor's potential with SanarUp, a credit product which offers additional income for the most difficult phases of their professional career. | Debt Financing / May 25, 2022 | ||
| The safest and friendliest e-prescribing tool, for doctors. The most convenient and affordable way for treatment adherence, for patients. | $17.7M / Series C / Oct 29, 2021 | ||
| The safest and friendliest e-prescribing tool, for doctors. The most convenient and affordable way for treatment adherence, for patients. | $59.3M / Series C / Jun 16, 2021 | ||
| Application that lets you find high quality healthcare services where you need. | $2M / Series A / May 01, 2020 | ||
| Sanar seeks to reshape future doctors and healthcare professionals to be much more efficient and assertive. We started the company as a knowledge platform; from the first moment they step into college, we follow the evolution of the professional throughout their career. Today, Sanar has become a platform for doctors entire lives, offering solutionsfor different stages of their journey: 1 - For students we offer SanarFlix; the platform has a multitude of content from the best teachers in the country and is helping the students to overcome the challenges they face in college. 2 - For the period of admission to medical residency, Sanar offers Sanar Medical Residency, a platform for test preparation to help doctors to enter the best programs in Brazil. 3 - For the general physician, we offer SanarYellow, a clinical decision-making tool with the most up-to-date guidelines, protocols, and drug interactions for point-of-care. 4 - Sanar is also helping to unlock the doctor's potential with SanarUp, a credit product which offers additional income for the most difficult phases of their professional career. | $11.5M / Series B / Apr 15, 2020 | ||
| The safest and friendliest e-prescribing tool, for doctors. The most convenient and affordable way for treatment adherence, for patients. | $4.6M / Series B / Feb 21, 2020 | ||
| The CareVoice is a Shanghai-based international company established in 2014, backed by top VC, Asian and Chinese healthcare investors. It is a health InsurTech company transforming healthcare experience to be more consumer-centric. They bring unique mobile-based and data-driven solutions that digitalize healthcare and insurance journey withconsumers' interest first. | $10M / Series A / Aug 22, 2019 | ||
| Blüüm is a health platform that offers augmented health services maximizing the quality of life at every stage. It enables users to enjoy a seamless health insurance journey all within the App such as a 24/7 virtual symptom checker, online clinic search, and appointment from an extensive medical network. Blüüm provides premium group medicalinsurance solutions at ‘affordable’ prices to startups and SMEs with complimentary employee benefits packages to support teams with different wellbeing and health needs. Currently, blüüm offers two insurance series which are tailored for sport lovers and SMEs, namely blüüm sport and blüüm team. | Seed / Jul 16, 2019 | ||
| Feegow Clinic is a clinical software that serves as a solution to all clinical and office management problems. The company exists since 2009 with the purpose of optimizing the routine of clinics, offices and hospitals throughout Brazil. Feegow Clinic meets the real needs of its audience, made up of different profiles in the health area. | $5.2M / Venture - Series Unknown / Jun 13, 2019 | ||
| See all 11 investments → | |||
Co-Investors
About DNA Capital
DNA Capital is an investment partnership specializing in multi-stage investments in the healthcare sector.
DNA Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Carlos de Barros Jorge Neto
Partner
|
|||
José Guinle
Partner
|
|||
Luiz Felipe D Martins Costa
Managing Partner
|
|||
|
Luiz Noronha
Partner
|
|||
Mario Sergio Ribeiro
Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Luiz Noronha invest in?
Luiz Noronha invests primarily in Health Care, Medical and Software startups, most often at Series A and Series B stage. Most of the 11 investments tracked by Shizune back companies in Brazil. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Luiz Noronha?
Public channels for Luiz Noronha include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Luiz Noronha last invest?
The most recent investment recorded for Luiz Noronha closed in May 2026. Shizune tracks 11 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
